A hosszú távú protonpumpagátló kezelés következményei felnőtteken

Translated title of the contribution: Adverse effects of long-term proton-pump inhibitor therapy on adults

Igaz Iván, Simonyi Gábor, Balogh Sándor, M. Szathmári

Research output: Contribution to journalArticle

Abstract

In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication.

Original languageHungarian
Pages (from-to)735-740
Number of pages6
JournalOrvosi Hetilap
Volume159
Issue number19
DOIs
Publication statusPublished - May 1 2018

Fingerprint

Proton Pump Inhibitors
Pharmaceutical Preparations
Magnesium Deficiency
Clostridium Infections
Vitamin B 12 Deficiency
Clostridium difficile
Bone Fractures
General Practitioners
Therapeutics
Acids
Long Term Adverse Effects

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A hosszú távú protonpumpagátló kezelés következményei felnőtteken. / Iván, Igaz; Gábor, Simonyi; Sándor, Balogh; Szathmári, M.

In: Orvosi Hetilap, Vol. 159, No. 19, 01.05.2018, p. 735-740.

Research output: Contribution to journalArticle

Iván, Igaz ; Gábor, Simonyi ; Sándor, Balogh ; Szathmári, M. / A hosszú távú protonpumpagátló kezelés következményei felnőtteken. In: Orvosi Hetilap. 2018 ; Vol. 159, No. 19. pp. 735-740.
@article{04967951ef5340c4a46e8881a02bec57,
title = "A hossz{\'u} t{\'a}v{\'u} protonpumpag{\'a}tl{\'o} kezel{\'e}s k{\"o}vetkezm{\'e}nyei felnőtteken",
abstract = "In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication.",
keywords = "Clostridium difficile, Dementia, Osteoporosis, Pneumonia, Proton pump inhibitor",
author = "Igaz Iv{\'a}n and Simonyi G{\'a}bor and Balogh S{\'a}ndor and M. Szathm{\'a}ri",
year = "2018",
month = "5",
day = "1",
doi = "10.1556/650.2018.31057",
language = "Hungarian",
volume = "159",
pages = "735--740",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "19",

}

TY - JOUR

T1 - A hosszú távú protonpumpagátló kezelés következményei felnőtteken

AU - Iván, Igaz

AU - Gábor, Simonyi

AU - Sándor, Balogh

AU - Szathmári, M.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication.

AB - In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term adverse effects. Among these adverse effects, the higher risk of bone fractures, the vitamin B12 and magnesium deficiencies and the higher risk of Clostridium difficile infection may be relevant. As these drugs are prescribed more and more frequently all over the world, the knowledge of the long-term adverse effects is very important not only for the specialists but for the general practitioners as well. In this review, the authors discuss the recent findings in this field, emphasising that the long-term use of these drugs must be based on an adequate and strong indication.

KW - Clostridium difficile

KW - Dementia

KW - Osteoporosis

KW - Pneumonia

KW - Proton pump inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85046702048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046702048&partnerID=8YFLogxK

U2 - 10.1556/650.2018.31057

DO - 10.1556/650.2018.31057

M3 - Article

VL - 159

SP - 735

EP - 740

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 19

ER -